RADIOTHERAPY SERVICES IN CANCER MANAGEMENT AT THE LAGOS UNIVERSITY TEACHING HOSPITAL, IDI-ARABA; PATIENTS PERSPECTIVE

Autor: Sowunmi AC, Ibitoye AZ, Alabi AO, Fatiregun OA

Publikováno v: Kanem Journal of Medical Sciences, Vol 9, Iss 1, Pp 24-32 (2015)

Background: Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. The incidence of cancer is on the increase, due to growth and ageing of the global population. More than half of all cancers (56.8%) and canc

Externí odkaz: https://doaj.org/article/ce56f6e2d7424c8b9ad8724e8ef9a9b5

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

Autor: Gillessen S; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biosciences, Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: silke.gillessen@eoc.ch., Turco F; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Davis ID; Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia., Efstathiou JA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., James ND; Institute of Cancer Research, London, UK., Shore N; Carolina Urologic Research Center and GenesisCare, Myrtle Beach, SC, USA., Small E; Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA., Smith M; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Tombal B; Division of Urology, Clinique Universitaire St. Luc, Brussels, Belgium., Zilli T; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biosciences, Università della Svizzera Italiana, Lugano, Switzerland., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Armstrong AJ; Center for Prostate and Urologic Cancer, Duke Cancer Institute, Duke University, Durham, NC, USA., Bastos DA; Hospital Sirio-Libanês, São Paulo, Brazil., Attard G; UCL Cancer Institute, University College London, London, UK., Axcrona K; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Urology, Akershus University Hospital, Lørenskog, Norway., Ayadi M; Salah Azaiz Institute, Medical School of Tunis, Tunis, Tunisia., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden., Blanchard P; Department of Radiation Oncology, Oncostat U1018 INSERM, Université Paris-Saclay, Gustave-Roussy, Villejuif, France., Bourlon MT; Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Briganti A; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Bulbul M; Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon., Buttigliero C; Department of Oncology, San Luigi Hospital, University of Turin, Orbassano, Italy., Caffo O; Medical Oncology Department, Santa Chiara Hospital, APSS, Trento, Italy., Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Cheng HH; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA USA., Chi KN; BC Cancer and University of British Columbia, Vancouver, Canada., Clarke CS; Research Department of Primary Care and Population Health, University College London, London, UK., Clarke N; The Christie and Salford Royal Hospitals, Manchester, UK., de Bono JS; Institute of Cancer Research, London, UK; Royal Marsden Hospital, London, UK., De Santis M; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria., Duran I; Medical Oncology Department, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Efstathiou E; Houston Methodist Cancer Center, Houston, TX, USA., Ekeke ON; Urology Division, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria., El Nahas TIH; Kasr Al Ainy Hospital, Cairo University, Giza, Egypt., Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia., Fanti S; Department of Nuclear Medicine, IRCCS AOU Bologna, Bologna, Italy., Fatiregun OA; Lagos State University Teaching Hospital, Ikeja, Nigeria., Feng FY; University of California-San Francisco, San Francisco, CA, USA., Fong PCC; Auckland City Hospital and University of Auckland, Auckland, New Zealand., Fonteyne V; Ghent University Hospital, Ghent, Belgium., Fossati N; Department of Surgery (Urology Service), Ente Ospedaliero Cantonale, Università della Svizzera Italiana Lugano, Switzerland., George DJ; Departments of Medicine and Surgery, Duke Cancer Institute, Duke University, Durham, NC, USA., Gleave ME; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Gravis G; Department of Medical Oncology, Institut Paoli Calmettes, Aix-Marseille Université, Marseille, France., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium, University Hospital Essen, Essen, Germany., Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Hope TA; Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA, USA., Horvath LG; Chris O'Brien Lifehouse, University of Sydney, Sydney, Australia., Hussain MHA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Jereczek-Fossa BA; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Radiation Oncology, European Institute of Oncology IRCCS, Milan, Italy., Jones RJ; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Joshua AM; Department of Medical Oncology, Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia., Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore., Keizman D; Genitourinary Unit, Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel., Khauli RB; Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon; Division of Urology, Carle-Illinois College of Medicine, Urbana, IL, USA., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Loeb S; Department of Urology and Population Health, New York University Langone Health, New York, NY, USA; Department of Surgery/Urology, Manhattan Veterans Affairs, New York, NY, USA., Mahal BA; Department of Radiation Oncology, University of Miami Sylvester Cancer Center, Miami, FL, USA., Maluf FC; Beneficiência Portuguesa de São Paulo, São Paulo, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, Brazil., Mateo J; Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Matheson D; Faculty of Education Health and Wellbeing, University of Wolverhampton, Walsall, UK., Matikainen MP; Department of Urology, Helsinki University Hospital, Helsinki, Finland., McDermott R; Department of Medical Oncology, St. Vincent's University Hospital and Cancer Trials, Dublin, Ireland., McKay RR; University of California-San Diego, Palo Alto, CA, USA., Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany., Morgans AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mrabti H; Institut National d'Oncologie, Mohamed V University, Rabat, Morocco., Mukherji D; Clemenceau Medical Center, Dubai, United Arab Emirates; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon., Murphy DG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Murthy V; Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Mutambirwa SBA; Department of Urology, Sefako Makgatho Health Science University, Dr. George Mukhari Academic Hospital, Medunsa, South Africa., Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Oh WK; Division of Hematology and Medical Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY, USA., Ost P; Department of Radiation Oncology, Iridium Network, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., O'Sullivan JM; Patrick G. Johnston Centre for Cancer Research, Queen's University, Belfast, UK., Padhani AR; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK., Parker C; Institute of Cancer Research, London, UK; Royal Marsden Hospital, London, UK., Poon DMC; Hong Kong Sanatorium and Hospital, Chinese University of Hong Kong, Hong Kong, China., Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Rabah DM; Cancer Research Chair and Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Rathkopf D; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reiter RE; University of California-Los Angeles, Los Angeles, CA, USA., Renard-Penna R; Department of Imagery, GRC 5 Predictive Onco-Uro, Pitie-Salpetriere Hospital, AP-HP, Sorbonne University, Paris, France., Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Saad F; Centre Hospitalier de Université de Montréal, Montreal, Canada., Sade JP; Instituto Alexander Fleming, Buenos Aires, Argentina., Sandhu S; Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Sartor OA; Department of Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Schaeffer E; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sharifi N; Desai Sethi Urology Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Skoneczna IA; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Soule HR; Prostate Cancer Foundation, Santa Monica, CA, USA., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, CA, USA., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Division of Hematology and Oncology, Meyer Cancer Center, New York Presbyterian Hospital, New York, NY, USA., Suzuki H; Department of Urology, Toho University Sakura Medical Center, Sakura, Japan., Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Thellenberg-Karlsson C; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Tilki D; Martini-Klinik Prostate Cancer Center and Department of Urology, University Hospital Hamburg Eppendorf, Hamburg, Germany., Türkeri LN; Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey., Uemura H; Yokohama City University Medical Center, Yokohama, Japan., Ürün Y; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey., Vale CL; MRC Clinical Trials Unit, University College London, London, UK., Vapiwala N; Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Walz J; Institut Paoli-Calmettes Cancer Center, Marseille, France., Yamoah K; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Yu EY; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA USA., Zapatero A; University Hospital La Princesa, Health Research Institute, Madrid, Spain., Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland.

Publikováno v: European urology [Eur Urol] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.

Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.

Autor: White JA; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Genetics, Morehouse School of Medicine, Atlanta, Georgia, USA., Kaninjing ET; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; School of Health and Human Performance, Georgia College & State University, Milledgeville, Georgia, USA., Adeniji KA; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; College of Health Sciences, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria., Jibrin P; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; College of Health Sciences, National Hospital Abuja, Abuja, Federal Capital Territory, Nigeria., Obafunwa JO; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Ogo CN; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Surgery, Federal Medical Centre, Abeokuta, Ogun State, Nigeria., Mohammed F; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology, Ahmadu Bello University, Zaria, Kaduna State, Nigeria., Popoola A; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; College of Health Sciences, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria., Fatiregun OA; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Clinical Oncology, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Oluwole OP; College of Health Sciences, University of Abuja, Abuja, Federal Capital Territory, Nigeria., Thorpe RJ Jr; Center for Health Disparities Solutions, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Karanam B; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria., Elhussin I; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Urology, Johns Hopkins University School of Medicine, Brady Urological Institute, Baltimore, Maryland, USA., Ambs S; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Tang W; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Davis M; Department of Genetics, Morehouse School of Medicine, Atlanta, Georgia, USA.; Department of Surgery, New York Presbyterian-Weill Cornell Medicine, New York, New York, USA., Polak P; Quest Diagnostics, Secaucus, New Jersey, USA., Campbell MJ; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Brignole KR; Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA., Rotimi SO; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Biochemistry and Covenant Applied Informatics and Communication Africa Centre of Excellence, Covenant University, Ota, Nigeria., Dean-Colomb W; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Piedmont Medical Oncology-Newnan, Newnan, Georgia, USA., Odedina FT; Center for Health Equity and Community Engagement Research, Mayo Clinic, Jacksonville, Florida, USA., Yates C; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Urology, Johns Hopkins University School of Medicine, Brady Urological Institute, Baltimore, Maryland, USA.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Publikováno v: The Prostate [Prostate] 2024 Apr; Vol. 84 (5), pp. 460-472. Date of Electronic Publication: 2024 Jan 08.

Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics.

Autor: Joseph A; NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria., Shour AR; Cancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WI.; Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI., Lasebikan NN; University of Nigeria Teaching Hospital, Enugu, Nigeria., Jimoh MA; University College Hospital, Ibadan, Nigeria.; Lakeshore Cancer Center, Lagos, Nigeria., Adegboyega BC; NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria., Nwachukwu E; National Hospital, Abuja, Nigeria., Awofeso O; Harvard Medical School, Boston, MA., Ajose A; Harvard Medical School, Boston, MA., Ibraheem A; Division of Hematology & Oncology, University of Illinois College of Medicine, Chicago, IL., Fatiregun OA; Lagos State University Teaching Hospital (LASUTH), Lagos, Nigeria., Ali-Gombe M; Federal Teaching Hospital, Gombe, Nigeria., Aliyu UM; Usman Danfodiyo University Teaching Hospital, Sokoto, Nigeria., Kotkat AE; NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria., Biyi-Olutunde OA; University of Port-Harcourt Teaching Hospital, Rivers State, Nigeria., Oboh EO; University of Benin Teaching Hospital, Edo, Nigeria., Zubairu IH; Ahmadu Bello University Teaching Hospital, Kaduna, Nigeria., Haider MR; Cancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WI., Olatosi B; Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI., Puthoff D; Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI., Onitilo AA; Cancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WI.; Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2023 Mar; Vol. 9, pp. e2200221.

Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.

Autor: White JA; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama., Kaninjing ET; Georgia College & State University, Milledgeville, Georgia., Adeniji KA; University of Ilorin Teaching Hospital, Nigeria, Ilorin., Jibrin P; National Hospital Abuja, Nigeria, Abuja., Obafunwa JO; Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Ogo CN; Federal Medical Centre, Abeokuta, Nigeria., Mohammed F; Ahmadu Bello University, Zaria Nigeria., Popoola A; University of Ilorin Teaching Hospital, Nigeria, Ilorin., Fatiregun OA; Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Oluwole OP; University of Abuja, FCT, Nigeria., Karanam B; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama., Elhussin I; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama., Ambs S; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, Bethesda, Maryland., Tang W; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, Bethesda, Maryland., Davis M; Department of Surgery, New York Presbyterian - Weill Cornell Medicine, New York, New York., Polak P; C2i Genomics, New York, New York., Campbell MJ; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio., Brignole KR; University of North Carolina Chapel Hill, North Carolina., Rotimi SO; Department of Biochemistry, Covenant University, Ota, Nigeria., Dean-Colomb W; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama.; Piedmont Medical Oncology - Newnan, Newnan, Georgia., Odedina FT; Center for Health Equity and Community Engagement Research, Mayo Clinic, Jacksonville, Florida., Martin DN; Division of Cancer Control and Population Sciences, NCI, Rockville, Maryland., Yates C; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Sep 16; Vol. 2 (9), pp. 1005-1016. Date of Electronic Publication: 2022 Sep 16 (Print Publication: 2022).